Trial Profile
Post-hoc analysis of desirudin [Iprivask] versus enoxaparin in patients undergoing elective total hip replacement (THR) surgery
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Jun 2015
Price :
$35
*
At a glance
- Drugs Desirudin (Primary) ; Enoxaparin sodium
- Indications Deep vein thrombosis; Venous thromboembolism
- Focus Registrational; Therapeutic Use
- 05 Nov 2010 New trial record.